Prestige Consumer Healthcare Inc. (PBH) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$0.88	$0.98	+11.4%	—	$265.7M	—
Q4 26	$1.39	$1.23	-11.5%	—	$281.6M	—
Q3 26	$1.16	$1.14	-1.7%	—	$283.4M	—
Q2 26	$0.97	$0.86	-11.3%	—	$274.1M	—
Q1 26	$0.99	$0.95	-4.0%	—	$249.5M	—
Q4 25	$1.29	$1.32	+2.3%	—	$296.5M	—
Q3 25	$1.16	$1.22	+5.2%	—	$290.3M	—
Q2 25	$1.08	$1.09	+0.9%	—	$283.8M	—
Q1 25	$0.86	$0.9	+4.7%	—	$267.1M	—
Q4 24	$1.14	$1.02	-10.5%	—	$277M	—
Q3 24	$1.04	$1.06	+1.9%	—	$282.7M	—
Q2 24	$1.07	$1.07	0.0%	—	$286.3M	—
Q1 24	$1.01	$1.06	+5.0%	—	$279.3M	—
Q4 23	$1.04	$1.07	+2.9%	—	$285.9M	—
Q3 23	$1.01	$1.04	+3.0%	—	$275.5M	—
Q2 23	$1	$1.02	+2.0%	—	$289.3M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$3.93	—	—	$1.1B	—
FY25	—	$4.32	—	—	$1.1B	—
FY24	—	$4.21	—	—	$1.1B	—
FY23	—	-$1.65	—	—	$1.1B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$882.1M	$1B	$975.8M	$963M	$943.4M	$1.1B	$1.1B	$1.1B	$1.1B	$1.1B
YoY change	+9.4%	+18%	-6.28%	-1.31%	-2.04%	+15.2%	+3.76%	-0.21%	+1.1%	-4.31%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	882.1M	1B	975.8M	963M	943.4M	1.1B	1.1B	1.1B	1.1B	1.1B
Cost of revenue	381.8M	464.7M	420.2M	410.8M	395.9M	466.2M	502.4M	500.9M	503.3M	493.1M
Gross profit	500.3M	576.5M	555.6M	552.2M	547.5M	620.6M	625.3M	624.4M	634.5M	595.6M
Gross margin	56.7%	55.4%	56.9%	57.3%	58%	57.1%	55.4%	55.5%	55.8%	54.7%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	217.5M	232.7M	462.3M	236.3M	223.7M	264.8M	252.4M	259.5M	263.9M	265.2M
Operating expenses	217.5M	232.7M	462.3M	236.3M	223.7M	264.8M	252.4M	259.5M	263.9M	265.2M
Operating income	257.5M	315.4M	66.2M	291.2M	299.8M	331M	347.8M	342.4M	349.2M	309.4M
Operating margin	29.2%	30.3%	6.79%	30.2%	31.8%	30.5%	30.8%	30.4%	30.7%	28.4%
Non-operating income, net	-53.3M	-102.4M	808K	-3.8M	-13.4M	-4.2M	-372.6M	756K	-17.4M	-9.6M
Pretax income	110.8M	107.1M	-38.1M	191.2M	204.1M	262.5M	-93.9M	276M	284.2M	257.5M
Income tax	41.5M	-232.5M	-2.3M	48.9M	39.4M	57.1M	-11.6M	66.7M	69.6M	67.2M
Net income	69.4M	339.6M	-35.8M	142.3M	164.7M	205.4M	-82.3M	209.3M	214.6M	190.3M
Net margin	7.87%	32.6%	-3.67%	14.8%	17.5%	18.9%	-7.3%	18.6%	18.9%	17.5%
EBITDA	283.4M	349.6M	97.5M	318.5M	331.4M	362M	378.1M	373.9M	374.5M	331.1M
EPS	1.31	6.4	-0.69	2.81	3.28	4.09	-1.65	4.21	4.32	3.93
Diluted EPS	1.3	6.34	-0.69	2.78	3.25	4.04	-1.65	4.17	4.29	3.91

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	286.3M	282.7M	277M	267.1M	283.8M	290.3M	296.5M	249.5M	274.1M	283.4M	281.6M	265.7M
Cost of revenue	126.3M	124.8M	125.2M	121.1M	126.4M	129.3M	126.5M	109.2M	122.5M	126.1M	135.3M	129.5M
Gross profit	160M	157.9M	151.8M	146M	157.4M	161M	170M	140.3M	151.6M	157.4M	146.3M	136.2M
Gross margin	55.9%	55.9%	54.8%	54.7%	55.5%	55.5%	57.3%	56.2%	55.3%	55.5%	51.9%	51.3%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	66.1M	65.5M	64M	68.3M	67.5M	64.1M	64.1M	63.4M	66.7M	69.7M	65.4M	78M
Operating expenses	66.1M	65.5M	64M	68.3M	67.5M	64.1M	64.1M	63.4M	66.7M	69.7M	65.4M	78M
Operating income	88.3M	86.8M	82.2M	72M	84.3M	92M	100.9M	71.8M	79.7M	82.5M	75.5M	52.5M
Operating margin	30.8%	30.7%	29.7%	27%	29.7%	31.7%	34%	28.8%	29.1%	29.1%	26.8%	19.8%
Non-operating income, net	-229K	-682K	429K	-496K	-395K	-353K	-16.2M	224K	-501K	-10M	708K	-34K
Pretax income	70.4M	69.6M	67.3M	58.4M	71.7M	80.2M	74M	61.8M	69.1M	61.8M	64.8M	38.5M
Income tax	16.9M	16.5M	17.9M	9.3M	17.3M	19.1M	23.8M	14.3M	26.9M	15.1M	10.8M	9.4M
Net income	53.6M	53M	49.5M	49.1M	54.4M	61M	50.1M	47.5M	42.2M	46.7M	53.9M	29.2M
Net margin	18.7%	18.8%	17.9%	18.4%	19.2%	21%	16.9%	19%	15.4%	16.5%	19.1%	11%
EBITDA	95.7M	93.8M	90.4M	79.7M	91.9M	98.5M	92M	79.6M	86.8M	80.1M	84.6M	61.2M
EPS	1.08	1.07	—	0.98	1.1	1.23	1.01	0.96	0.86	0.98	1.14	0.61
Diluted EPS	1.07	1.06	—	0.98	1.09	1.22	1	0.95	0.86	0.97	1.13	0.61

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	2.9B	1.8B	1.6B	1.9B	2.2B	2.7B	3.1B	3.6B	4.3B	2.9B	2.2B
Enterprise value	5.1B	3.8B	3.3B	3.5B	3.7B	4.1B	4.4B	4.7B	5.2B	3.9B	4.2B
Shares outstanding	53M	53.1M	52.1M	50.7M	50.2M	50.3M	49.9M	49.8M	49.7M	48.5M	48.5M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	42.4	5.27	—	13.1	13.4	13	—	17.2	19.9	15.1	13.1
P/S	3.34	1.72	1.6	1.93	2.35	2.45	2.77	3.21	3.76	2.64	2.01
P/B	3.58	1.52	1.42	1.59	1.63	1.69	2.16	2.18	2.33	1.52	1.16
EV/EBITDA	18	10.7	34.1	11.1	11.2	11.4	11.7	12.6	13.9	11.6	12.9
EV/Sales	5.78	3.6	3.41	3.67	3.92	3.81	3.93	4.18	4.59	3.54	3.79
Earnings yield	2.36%	19%	—	7.65%	7.44%	7.72%	—	5.8%	5.02%	6.63%	7.61%
FCF yield	4.95%	11%	11.5%	10.9%	9.64%	9.41%	7.1%	6.63%	5.69%	8.58%	6.65%
PEG	—	—	—	—	—	—	—	—	—	—	-0.36

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	56.7%	55.4%	56.9%	57.3%	58%	57.1%	55.4%	55.5%	55.8%	54.7%	51.3%
Operating margin	29.2%	30.3%	6.79%	30.2%	31.8%	30.5%	30.8%	30.4%	30.7%	28.4%	20.8%
Net margin	7.87%	32.6%	-3.67%	14.8%	17.5%	18.9%	-7.3%	18.6%	18.9%	17.5%	15.6%
ROE	8.44%	28.8%	-3.27%	12.2%	12.1%	13%	-5.69%	12.6%	11.7%	10.1%	9.12%
ROA	1.77%	9.03%	-1.04%	4.05%	4.8%	5.6%	-2.45%	6.31%	6.31%	5.45%	4.58%
ROIC	5.42%	10%	2.31%	7.62%	8.52%	8.47%	12.6%	9.45%	9.48%	7.97%	5.47%
Return on tangible assets	-2.22%	-11.2%	1.31%	-5.48%	-6.15%	-7.13%	3.45%	-8.8%	-9.57%	-8.39%	-5.34%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	2.06	2.46	2.37	2.44	2.21	2.04	2.44	3.2	4.2	3.57	3.23
Quick ratio	1.35	1.5	1.43	1.67	1.27	1.21	1.43	2.02	2.82	2.25	1.99
Debt / equity	2.67	1.69	1.64	1.51	1.12	0.95	0.94	0.69	0.57	0.55	1.08
Debt / assets	0.56	0.53	0.52	0.5	0.44	0.41	0.41	0.34	0.31	0.3	0.45
Net debt / EBITDA	7.59	5.61	18.2	5.25	4.47	4.09	3.46	2.92	2.53	2.96	6.33
Interest coverage	2.18	2.01	0.64	2.99	3.48	5.08	-0.36	5.11	6.97	7.08	6.08
Effective tax rate	37.4%	0%	0%	25.6%	19.3%	21.7%	0%	24.2%	24.5%	26.1%	26.6%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	16.7	19.6	18.7	19	18.8	21.6	22.6	22.6	22.9	22.5	23
EPS (basic)	1.31	6.4	-0.69	2.81	3.28	4.09	-1.65	4.21	4.32	3.93	3.93
EPS (diluted)	1.3	6.34	-0.69	2.78	3.25	4.04	-1.65	4.17	4.29	3.91	3.57
Book value per share	15.5	22.2	21	23.1	27.1	31.4	29	33.3	36.9	39	40.5
FCF per share	2.75	3.72	3.43	3.99	4.25	4.98	4.45	4.81	4.9	5.09	4.94
Cash per share	0.79	0.61	0.53	1.87	0.64	0.54	1.17	0.93	1.97	1.32	1.88
Capex per share	0.05	0.24	0.2	0.29	0.44	0.19	0.16	0.19	0.17	—	—

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	0.33%	1.2%	1.07%	1.51%	2.36%	0.89%	0.69%	0.85%	0.72%	—	—
Capex / operating cash flow	3.09%	12.1%	-21.1%	7.23%	9.32%	3.93%	-5.06%	3.5%	3.62%	—	—
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Yield

—

trailing twelve months

Frequency

—

Last dividend

$0.475

ex-dividend Sep 27, 2018

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Sep 27, 2018	$0.475

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	$286.3M	$282.7M	$277M	$267.1M	$283.8M	$290.3M	$296.5M	$249.5M	$274.1M	$283.4M	$281.6M	$265.7M
YoY change	-1.02%	+2.62%	-3.11%	-4.36%	-0.88%	+2.68%	+7.05%	-6.59%	-3.41%	-2.37%	-5.03%	+6.48%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	41.9M	32.5M	27.5M	94.8M	32.3M	27.2M	58.5M	46.5M	97.9M	63.9M
Receivables	135.3M	140.1M	148.1M	150M	114.7M	159M	183.4M	185M	202M	208.6M
Inventory	115.6M	118.5M	119.9M	116M	115M	120.3M	162.1M	138.7M	147.7M	159.1M
Total current assets	334.4M	303.5M	300.9M	365.7M	269.8M	293.3M	391.7M	375M	448.3M	431.5M
Property, plant & equipment	37.4M	38.8M	37.2M	74.2M	75.6M	69.5M	59.1M	58.3M	96.5M	122.4M
Goodwill & intangibles	7B	6.8B	6.2B	6.1B	6.1B	6.6B	5.7B	5.7B	5.6B	5.8B
Total assets	3.9B	3.8B	3.4B	3.5B	3.4B	3.7B	3.4B	3.3B	3.4B	3.5B
Accounts payable	70.2M	61.4M	56.6M	62.4M	46M	55.8M	62.7M	39M	18.9M	22.8M
Short-term debt	—	—	—	6.8M	8.4M	9.1M	9.8M	6.2M	8.5M	12.6M
Total current liabilities	162M	123.2M	127M	149.9M	122.1M	143.4M	160.7M	117M	106.6M	120.9M
Long-term debt	2.2B	2B	1.8B	1.8B	1.5B	1.5B	1.4B	1.1B	1B	1B
Total liabilities	3.1B	2.6B	2.3B	2.3B	2.1B	2.1B	1.9B	1.7B	1.6B	1.6B
Shareholders' equity	822.5M	1.2B	1.1B	1.2B	1.4B	1.6B	1.4B	1.7B	1.8B	1.9B
Total debt	2.2B	2B	1.8B	1.8B	1.5B	1.5B	1.4B	1.1B	1B	1B
Net debt	2.2B	2B	1.8B	1.7B	1.5B	1.5B	1.3B	1.1B	946.4M	981.6M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Cash & short-term investments	60.1M	63.6M	46.5M	34.3M	51.5M	50.9M	97.9M	139.5M	119.1M	62.4M	63.9M	89.1M
Receivables	158.5M	174.3M	185M	171.7M	163.5M	167.3M	202M	168.4M	199M	190.5M	208.6M	187.4M
Inventory	161.3M	148.6M	138.7M	152M	156.2M	151.5M	147.7M	153.1M	159M	163.6M	159.1M	190.2M
Total current assets	388.2M	393.8M	375M	368.7M	380.7M	377.2M	448.3M	480.5M	497.4M	433.4M	431.5M	496.8M
Property, plant & equipment	85.7M	83.3M	58.3M	86.3M	83.7M	108.1M	96.5M	124.9M	121.9M	174.7M	122.4M	164.2M
Goodwill & intangibles	5.7B	5.7B	5.7B	5.7B	5.7B	5.7B	5.6B	5.6B	5.6B	5.8B	5.8B	7.8B
Total assets	3.3B	3.3B	3.3B	3.3B	3.3B	3.3B	3.4B	3.4B	3.4B	3.5B	3.5B	4.6B
Accounts payable	44.4M	39.3M	39M	39.6M	31.2M	19.5M	18.9M	22.2M	41.9M	42.9M	22.8M	36.8M
Short-term debt	9.6M	7.8M	6.2M	4.4M	2.7M	6.9M	8.5M	8.6M	8.6M	8.6M	12.6M	23.8M
Total current liabilities	129.7M	127.4M	117M	114.1M	106.9M	102.5M	106.6M	109.7M	134.6M	139.6M	120.9M	153.8M
Long-term debt	1.3B	1.2B	1.1B	1.1B	1.1B	1B	1B	1B	1B	1.1B	1B	2B
Total liabilities	1.8B	1.7B	1.7B	1.6B	1.6B	1.5B	1.6B	1.6B	1.6B	1.7B	1.6B	2.7B
Shareholders' equity	1.5B	1.6B	1.7B	1.7B	1.7B	1.8B	1.8B	1.9B	1.8B	1.8B	1.9B	1.9B
Total debt	1.3B	1.2B	1.1B	1.1B	1.1B	1B	1B	1B	1B	1.1B	1B	2.1B
Net debt	1.2B	1.1B	1.1B	1.1B	1B	976.3M	946.4M	903.2M	921.9M	1B	981.6M	2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	69.4M	339.6M	-35.8M	142.3M	164.7M	205.4M	-82.3M	209.3M	214.6M	190.3M
Depreciation & amortization	25.8M	33.4M	31.8M	29M	30.2M	32.1M	32.6M	30.7M	30.2M	31.3M
Stock-based compensation	8.1M	8.9M	7.4M	7.6M	8.5M	9M	12.4M	14M	11.2M	10.8M
Change in working capital	-13.8M	-18M	-18.9M	-4M	12.5M	-22M	-66.9M	-15.4M	-53.6M	-13.2M
Operating cash flow	93.5M	103.5M	-49.7M	201.5M	238.8M	245.4M	-153.8M	273.1M	227.2M	257.6M
Capital expenditure	-2.9M	-12.5M	-10.5M	-14.6M	-22.2M	-9.6M	-7.8M	-9.6M	-8.2M	—
Investing cash flow	-694.6M	-11.6M	55.4M	-16.6M	-22.2M	-256.3M	-15.4M	-20.1M	-17.5M	-125.7M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	0	-50M	-56.7M	-11.9M	0	-50M	-25M	-51.5M	-156.3M
Financing cash flow	451.9M	-255.6M	-297.3M	-252.8M	-352.3M	-99.6M	-213.2M	-259.1M	-196.9M	-200.3M
Net change in cash	-149.1M	-163.6M	-291.6M	-67.9M	-135.7M	-110.5M	-382.4M	-6.1M	12.8M	-68.4M
Free cash flow	145.7M	197.6M	178.8M	202.6M	213.4M	250.3M	221.9M	239.4M	243.3M	246.4M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Net income	53.6M	53M	49.5M	49.1M	54.4M	61M	50.1M	—	—	—	—	29.2M
Depreciation & amortization	7.6M	7.6M	7.8M	8.1M	7.9M	6.9M	7.3M	7.7M	7.7M	7.6M	8.4M	8.8M
Stock-based compensation	3.7M	2.4M	3.7M	3.4M	2.1M	2.9M	2.7M	3.7M	1.8M	2.7M	2.6M	4M
Change in working capital	-9.1M	-5.2M	8.6M	-8.9M	-4.7M	-16.5M	-23.5M	23.7M	-17.9M	-2.4M	-16.6M	11.7M
Operating cash flow	64.1M	66.2M	81M	54.5M	65.6M	59.5M	47.5M	79M	57.5M	78.3M	42.8M	70.8M
Capital expenditure	-2.9M	-2M	-3.1M	-1.2M	-2M	-1.6M	-3.5M	—	—	—	—	—
Investing cash flow	-2.9M	-4.5M	-3.1M	-2.1M	-2M	-1.6M	-3.5M	-1.1M	-827K	0	1.8M	-1.1B
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	0	0	-26M	-11.8M	-2.4M	-11.3M	-34.8M	-75M	-45.8M	-690K	0
Financing cash flow	-55.7M	-66.5M	-75.7M	-67.5M	-52.8M	-62.6M	-13.9M	-39.4M	-75.7M	-46.7M	-41.5M	1B
Net change in cash	5.5M	-4.8M	2.1M	-15.2M	10.8M	-4.6M	30.1M	38.5M	-19M	31.6M	3.2M	29.2M
Free cash flow	59.5M	69.5M	63.8M	53.6M	67.8M	63.5M	58.4M	78.2M	55.4M	75.3M	37.6M	67.1M

Prestige Consumer Healthcare Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement